The global microfluidics market is expected to grow at a CAGR of 12.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing demand for point-of-care diagnostics and growing need for drug delivery systems. The polymer segment is expected to dominate the global microfluidics market during the forecast period, owing to its wide range of applications in various industries such as pharmaceuticals, in vitro diagnostics, and drug delivery.
North America accounted for the largest share of the global microfluidics market in 2018 due to high adoption rates of point-of-care diagnostic devices and increasing demand for drug delivery systems. Europe followed North America with a share of 27% in 2018 due to high adoption rates of point-of-care diagnostic devices and growing need for drug delivery systems. Asia Pacific was third with a share of 18% in 2018 due to high adoption rates of point-of-care diagnostic devices and growing need for drug delivery systems.
-Microfluidics is a technology that has been around for decades, but it is only recently that the technology has been able to be applied to a wide range of industries.
-The microfluidics market is expected to grow at an annual rate of 10% through 2020.
-Microfluidics can be used in many different industries, including healthcare, pharmaceuticals, and food and beverage.
-The use of microfluidics in the healthcare industry will continue to grow as more people are diagnosed with chronic diseases such as diabetes and cancer.
-In addition, the use of microfluidics in pharmaceuticals will also continue to grow as more drugs are developed for treating chronic diseases.
Industry Growth Insights published a new data on “Microfluidics Market”. The research report is titled “Microfluidics Market research by Types (Polymer, Glass, Silica Gel, Other), By Applications (In Vitro Diagnostic, Pharmaceuticals, Drug Delivery, Other), By Players/Companies Danaher, Thermo Fisher Scientific, Perkinelmer, Agilent Technologies, Bio-Rad Laboratories, Becton, Dickinson, Illumina, F. Hoffmann-La Roche, Fluidigm, Dolomite Microfluidics, Qiagen, Abbott Laboratories, Biomerieux, Microfluidic Chipshop, Elveflow, Cellix, Micronit Microtechnologies”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Microfluidics Market Research Report
By Type
Polymer, Glass, Silica Gel, Other
By Application
In Vitro Diagnostic, Pharmaceuticals, Drug Delivery, Other
By Companies
Danaher, Thermo Fisher Scientific, Perkinelmer, Agilent Technologies, Bio-Rad Laboratories, Becton, Dickinson, Illumina, F. Hoffmann-La Roche, Fluidigm, Dolomite Microfluidics, Qiagen, Abbott Laboratories, Biomerieux, Microfluidic Chipshop, Elveflow, Cellix, Micronit Microtechnologies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Microfluidics Market Report Segments:
The global Microfluidics market is segmented on the basis of:
Types
Polymer, Glass, Silica Gel, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
In Vitro Diagnostic, Pharmaceuticals, Drug Delivery, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Danaher
- Thermo Fisher Scientific
- Perkinelmer
- Agilent Technologies
- Bio-Rad Laboratories
- Becton, Dickinson
- Illumina
- F. Hoffmann-La Roche
- Fluidigm
- Dolomite Microfluidics
- Qiagen
- Abbott Laboratories
- Biomerieux
- Microfluidic Chipshop
- Elveflow
- Cellix
- Micronit Microtechnologies
Highlights of The Microfluidics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Polymer
- Glass
- Silica Gel
- Other
- By Application:
- In Vitro Diagnostic
- Pharmaceuticals
- Drug Delivery
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Microfluidics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Microfluidics is a technology that uses small channels and droplets to control the flow of fluids. This technology can be used in many different applications, including drug delivery, environmental monitoring, and chemical synthesis.
Some of the major players in the microfluidics market are Danaher, Thermo Fisher Scientific, Perkinelmer, Agilent Technologies, Bio-Rad Laboratories, Becton, Dickinson, Illumina, F. Hoffmann-La Roche, Fluidigm, Dolomite Microfluidics, Qiagen, Abbott Laboratories, Biomerieux, Microfluidic Chipshop, Elveflow, Cellix, Micronit Microtechnologies.
The microfluidics market is expected to grow at a compound annual growth rate of 12.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Microfluidics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Microfluidics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Microfluidics Market - Supply Chain
4.5. Global Microfluidics Market Forecast
4.5.1. Microfluidics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Microfluidics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Microfluidics Market Absolute $ Opportunity
5. Global Microfluidics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Microfluidics Market Size and Volume Forecast by Type
5.3.1. Polymer
5.3.2. Glass
5.3.3. Silica Gel
5.3.4. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Microfluidics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Microfluidics Market Size and Volume Forecast by Application
6.3.1. In Vitro Diagnostic
6.3.2. Pharmaceuticals
6.3.3. Drug Delivery
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Microfluidics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Microfluidics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Microfluidics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Microfluidics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Microfluidics Demand Share Forecast, 2019-2026
9. North America Microfluidics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Microfluidics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Microfluidics Market Size and Volume Forecast by Application
9.4.1. In Vitro Diagnostic
9.4.2. Pharmaceuticals
9.4.3. Drug Delivery
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Microfluidics Market Size and Volume Forecast by Type
9.7.1. Polymer
9.7.2. Glass
9.7.3. Silica Gel
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Microfluidics Demand Share Forecast, 2019-2026
10. Latin America Microfluidics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Microfluidics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Microfluidics Market Size and Volume Forecast by Application
10.4.1. In Vitro Diagnostic
10.4.2. Pharmaceuticals
10.4.3. Drug Delivery
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Microfluidics Market Size and Volume Forecast by Type
10.7.1. Polymer
10.7.2. Glass
10.7.3. Silica Gel
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Microfluidics Demand Share Forecast, 2019-2026
11. Europe Microfluidics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Microfluidics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Microfluidics Market Size and Volume Forecast by Application
11.4.1. In Vitro Diagnostic
11.4.2. Pharmaceuticals
11.4.3. Drug Delivery
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Microfluidics Market Size and Volume Forecast by Type
11.7.1. Polymer
11.7.2. Glass
11.7.3. Silica Gel
11.7.4. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Ptential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Microfluidics Demand Share, 2019-2026
12. Asia Pacific Microfluidics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Microfluidics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Microfluidics Market Size and Volume Forecast by Application
12.4.1. In Vitro Diagnostic
12.4.2. Pharmaceuticals
12.4.3. Drug Delivery
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Microfluidics Market Size and Volume Forecast by Type
12.7.1. Polymer
12.7.2. Glass
12.7.3. Silica Gel
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Microfluidics Demand Share, 2019-2026
13. Middle East & Africa Microfluidics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Microfluidics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Microfluidics Market Size and Volume Forecast by Application
13.4.1. In Vitro Diagnostic
13.4.2. Pharmaceuticals
13.4.3. Drug Delivery
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Microfluidics Market Size and Volume Forecast by Type
13.7.1. Polymer
13.7.2. Glass
13.7.3. Silica Gel
13.7.4. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Microfluidics Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Microfluidics Market: Market Share Analysis
14.2. Microfluidics Distributors and Customers
14.3. Microfluidics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Danaher
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Thermo Fisher Scientific
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Perkinelmer
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Agilent Technologies
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bio-Rad Laboratories
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Becton, Dickinson
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Illumina
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. F. Hoffmann-La Roche
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Fluidigm
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Dolomite Microfluidics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Qiagen
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Abbott Laboratories
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Biomerieux
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Microfluidic Chipshop
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Elveflow
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Cellix
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Micronit Microtechnologies
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
